Maxwell Biotech Group MBG

Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs. MBG in the Media. Therapeutic focus Chronic viralhepatitis B HBV; chronic hepatitis D HDV. BNV-222, aldose reductase inhibitor ARI. Therapeutic focus diabetic peripheral neuropathy. The first drug in the companys portfolio is SQ109. For the treatment of multidrug-resistant TB MDR-TB. Therapeutic focus asthma and other respiratory diseases.

OVERVIEW

The site maxwellbio.com currently has a traffic classification of zero (the lower the higher page views). We have traversed seven pages within the domain maxwellbio.com and found eighty-one websites referencing maxwellbio.com. We have detected one contacts and locations for maxwellbio.com to help you communicate with them. We have detected one public communication platforms linked to maxwellbio.com. The site maxwellbio.com has been on the internet for seven hundred and two weeks, eighteen days, eighteen hours, and two minutes.
Pages Parsed
7
Links to this site
81
Contacts
1
Addresses
1
Social Links
1
Online Since
Dec 2010

MAXWELLBIO.COM TRAFFIC

The site maxwellbio.com has seen variant quantities of traffic within the past the year.
Traffic for maxwellbio.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for maxwellbio.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for maxwellbio.com

Date Range

All time
This Year
Last Year
Last Month

MAXWELLBIO.COM HISTORY

The site maxwellbio.com was started on on December 01, 2010. This web site was updated on December 10, 2010. This site will go back on the market on the date of November 30, 2014. As of today, it is seven hundred and two weeks, eighteen days, eighteen hours, and two minutes old.
REGISTERED
December
2010
UPDATED
December
2010
EXPIRED
November
2014

DOMAIN PERIOD

13
YEARS
5
MONTHS
19
DAYS

LINKS TO WEBSITE

Остерос Биомедика

Остерос Биомедика частная российская биотехнологическая компания, созданная в 2012 с целью разработки и коммерциализации препаратов для лечения костных поражений, вызванных злокачественными новообразованиями. Остерос Биомедика частная биотехнологическая компания. Цель компании Остерос Биомедика - разработка препаратов для лечения костных поражений, вызванных злокачественными новообразованиями. Компания Остерос Биомедика начала клиническое исследование 1 фазы. Stay informed on our latest news! .

WHAT DOES MAXWELLBIO.COM LOOK LIKE?

Desktop Screenshot of maxwellbio.com Mobile Screenshot of maxwellbio.com Tablet Screenshot of maxwellbio.com

CONTACTS

Dmitry S Popov

Dmitry S Popov

1 B. Yakimanka str

Moscow, 119180

RU

MAXWELLBIO.COM SERVER

We observed that the main root page on maxwellbio.com took three thousand nine hundred and thirty-five milliseconds to load. We could not discover a SSL certificate, so our web crawlers consider this site not secure.
Load time
3.935 sec
SSL
NOT SECURE
IP
31.31.196.134

NAME SERVERS

ns3.nic.ru
ns4.nic.ru
ns8.nic.ru

WEBSITE ICON

SERVER SOFTWARE

We detected that this domain is implementing the nginx operating system.

SITE TITLE

Maxwell Biotech Group MBG

DESCRIPTION

Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs. MBG in the Media. Therapeutic focus Chronic viralhepatitis B HBV; chronic hepatitis D HDV. BNV-222, aldose reductase inhibitor ARI. Therapeutic focus diabetic peripheral neuropathy. The first drug in the companys portfolio is SQ109. For the treatment of multidrug-resistant TB MDR-TB. Therapeutic focus asthma and other respiratory diseases.

PARSED CONTENT

The site maxwellbio.com states the following, "Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs." I noticed that the webpage stated " Therapeutic focus Chronic viralhepatitis B HBV; chronic hepatitis D HDV." They also stated " BNV-222, aldose reductase inhibitor ARI. Therapeutic focus diabetic peripheral neuropathy. The first drug in the companys portfolio is SQ109. For the treatment of multidrug-resistant TB MDR-TB. Therapeutic focus asthma and other respiratory diseases."

ANALYZE MORE DOMAINS

The Life and Times of Maxwell

The Life and Times of Maxwell. Friday, March 3, 2017. I sleep until 6am, and then I wake up my Dads EVERY MORNING. I now eat a variety of foods, like pasta, taquitos, hot dogs, hamburgers, apples and tater-tots. I just won a perfect attendance award at school.

Maxwell Blade Hot Springs, AR

Foul Play Caberet on Friday, April 20th. Rick Williams and Maxwell Blade won the Downtown Trailblazer Award for their incredible renovation of the Malco Theater at the Hot Springs Metro Partnership Economic Development Awards on March 13th, 2018. Saturday - April 7th - 8pm. Friday - April 13th - 8pm. Saturday - April 14th - 8pm. Friday - April 20th - Foul Play Follies - 8pm. Saturday - April 21st - 8pm. Saturday - April 28th - 8pm.

Custom Made Modern Design Furniture, New York Maxwell Blake

You have no items in your shopping cart. You have no items in your shopping cart. Irving armchair - wood legs. Dauria wing chair and ottoman. Hamill 78 oval table desk - marble top. Seat belt outdoor chair - black. Morris lounge chair - leather.

Maxwell Bohr

RUA PORTO ALEGRE, 212 - JD.